Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000486614 | SCV000573069 | pathogenic | not provided | 2017-07-20 | criteria provided, single submitter | clinical testing | The c.105dupG variant in the MEN1 gene has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. This duplication causes a frameshift starting with codon Leucine 36, changes this amino acid to an Alanine residue and creates a premature Stop codon at position 81 of the new reading frame, denoted p.Leu36AlafsX81. This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. Based on currently available evidence, we consider c.105dupG to be pathogenic. |
Labcorp Genetics |
RCV001851251 | SCV002145404 | pathogenic | Multiple endocrine neoplasia, type 1 | 2020-12-27 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Leu36Alafs*81) in the MEN1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MEN1 are known to be pathogenic (PMID: 12112656, 17853334). This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with MEN1-related conditions. ClinVar contains an entry for this variant (Variation ID: 423376). For these reasons, this variant has been classified as Pathogenic. |